October 6, 2021 07:10 AM EDTUpdated 07:27 AM
Coronavirus

Covid-19 roundup: Sin­ga­pore and South Ko­rea are the lat­est to ink sup­ply deals for break­through Covid-19 pill

Josh Sullivan

An­oth­er coun­try in Asia has land­ed a sup­ply and pur­chase agree­ment with Mer­ck for its promis­ing oral Covid-19 an­tivi­ral drug. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Out­look's shares crash as wet AMD drug flunks Phase 3 test

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times